FDA Approved: VELTASSA — Supplemental Application (Vifor Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VelTassa (patiromer) submitted by Vifor Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia

Drugs mentioned

• Veltassa (patiromer)

Snippet

SUPPL AP for VELTASSA (PATIROMER)